Background: Publication of the 2015 American Thyroid Association (ATA) management
guidelines for adult patients with thyroid nodules and differentiated thyroid cancer was met …

Background: I-131 has been used in the therapy of well-differentiated thyroid cancer for over
50 years. Although the benefits and risks of I-131 remain issues of controversy and research …

OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of
optimizing outcomes. This principle is being applied to radioactive iodine therapy …

Background: The American Thyroid Association (ATA), the European Association of Nuclear
Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and …

Recently the American Thyroid Association (ATA) released the third version of one of the
most cited differentiated thyroid cancer (DTC) guidelines under the title B2015 American …

The purpose of this guideline is to assist nuclear medicine practitioners in evaluating
patients for therapy with 131I (sodium iodide) for benign or malignant conditions of the …

This article discusses several aspects of the evaluation and management of differentiated
thyroid carcinoma that are changing or may change in the near future. Although …

Background: The optimal management of high-risk patients with differentiated thyroid cancer
(DTC) consists of thyroidectomy followed by radioiodine (131I) therapy. The prescribed …

Abstract purpose: To determine the long-term impact of medical and surgical treatment of
well differentiated papillary and follicular thyroid cancer. methods: Patients with papillary …

Introduction The purpose of the present guidelines on the radioiodine therapy (RAIT) of
differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear …